Document is current
Any future updates will be listed below
-
Authors
Vainio, Petri J.
Hietasalo, Pauliina
Koivisto, Anna-Liisa
Kääriäinen, Susanna
Turunen, Jari
Virtala, Mika
Vuorinen, Jouni
Scheinin, Mika http://orcid.org/0000-0001-7579-9126
-
Funding
Funding for this research was provided by:
City of Pori
Kuusisto Group
Osuuskauppa Keula
- License Information
-
More Information
Article History
Received: 15 December 2020
Accepted: 18 December 2020
First Online: 11 January 2021
Ethics approval and consent to participate
: Conditional approval of protocol version 1 was received on 10 July 2020 from Finland´s National Committee on Medical Research Ethics, TUKIJA (Dnro 88/06.00.01/2020). Final approval of protocol version 2 and the revised ICF was received from the same ethics committee on 17 August 2020.The authors certify that this trial has received ethical approval from the appropriate ethical committee as described above. Potential study subjects will first receive written and verbal information on the study and will have an opportunity to ask questions. If a subject decides to participate in the trial, written informed consent will be obtained before any study-related procedures are performed. A copy of the signed ICF will be provided to the subject.
: Not applicable
: SK and MS are employed by Clinical Research Services Turku – CRST Oy, a contract research organization engaged in commercial clinical trials for the pharmaceutical industry. All authors declare that they have no competing interests related to this trial.
